Delivery Order SPE2DB20D1100-SPE2DB25FE0R5
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 8, 2025, for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30-count). This firm fixed price delivery order, valued at $1,111.81, represents a competitive award with no set-aside designation. The contract is a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). Valued at $1,463.52 with a firm fixed price structure, this non-set-aside competitive award was executed on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract is issued as a child delivery order under...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,409.88 by the Defense Logistics Agency's Medical Supply Chain for the supply of Telmisartan-HCTZ 80-12.5 mg tablet, unit dose packaging, in quantities of 30 units. The contract, awarded on August 29, 2025, with a completion date of September 2, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30 count) valued at $4,513.88. This competitively awarded, firm fixed-price delivery order was issued on September 12, 2025, with an ultimate completion date of September 15, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency on August 1, 2025, for Telmisartan-HCTZ 80-25 mg tablets in unit dose packages of 30 units. This is a firm fixed-price delivery order with a ceiling value of $3,805.45 and an ultimate completion date of August 4, 2025. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) with a ceiling value of $1,441.33. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, executing under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The prime contract, valued at...
- The Defense Logistics Agency awarded a $3,549.93 delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets (30-count unit dose packaging) on August 19, 2025, with completion scheduled for August 20, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The delivery location is specified as Conshohocken, PA, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $11,013.30 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). This delivery order is a non-set-aside award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The ultimate completion date for this delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30 count), valued at $15,288.87. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This order is...
- The Defense Logistics Agency awarded a $3,157.92 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under AmerisourceBergen's...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0R5Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 14, 2025, for Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30-count supply). The contract, issued under firm fixed-price terms with a ceiling value of $1,443.64, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was made through competitive procurement with no set-aside designation. This pharmaceutical supply supports military and federal healthcare systems requiring antihypertensive medications for troop medical readiness and veteran care. The delivery order is scheduled for completion by August 15, 2025, with performance at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. As a prime vendor under the DLA's comprehensive global pharmaceutical support program, AmerisourceBergen supplies an extensive portfolio of medications and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. The company's contract history demonstrates consistent capability to fulfill competitive federal medical procurement requirements across multiple therapeutic domains, positioning it as a critical supplier within the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/14/25 |